Literature DB >> 19450723

Activation of PH-domain leucine-rich protein phosphatase 2 (PHLPP2) by agonist stimulation in cardiac myocytes expressing adenylyl cyclase type 6.

Mei Hua Gao1, Atsushi Miyanohara, James R Feramisco, Tong Tang.   

Abstract

The Ser/Thr-specific phosphatase PHLPP (pleckstrin homology domain leucine-rich repeat protein phosphatase) regulates the amplitude and duration of agonist-evoked Akt signaling by dephosphorylating the hydrophobic motif (Ser473) of Akt, therefore inactivating Akt. We recently reported that gene transfer of adenylyl cyclase type 6 (AC6) into neonatal rat cardiac myocytes was associated with increased Akt phosphorylation and activity. To determine the underlying mechanisms for AC6-associated increase in Akt activation, we determined how AC6 gene transfer regulated the activity of PHLPP2 (one of the three PHLPP family phosphatases) in neonatal rat cardiac myocytes. We found that increased Akt activity was associated with inhibition of PHLPP2 activity by AC6. AC6 was physically associated with PHLPP2, which prevents PHLPP2-mediated Akt dephosphorylation. However, isoproterenol or forskolin stimulation immediately activated PHLPP2, which resulted in markedly dephosphorylation of Akt at Ser473. Activation of PHLPP2 by isoproterenol and forskolin was cAMP-independent, but required an intact cytoplasmic domain of AC6. Mutation in the cytoplasmic domain of AC6 abolished agonist-induced PHLPP2 activation. This novel bidirectional regulation of Akt activity may contribute to the unexpected favorable effects of AC6 on the failing heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450723      PMCID: PMC2693944          DOI: 10.1016/j.bbrc.2009.04.110

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes.

Authors:  Andrea L Bauman; Joseph Soughayer; Bao T Nguyen; Debbie Willoughby; Graeme K Carnegie; Wei Wong; Naoto Hoshi; Lorene K Langeberg; Dermot M F Cooper; Carmen W Dessauer; John D Scott
Journal:  Mol Cell       Date:  2006-09-15       Impact factor: 17.970

2.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.

Authors:  David A Guertin; Deanna M Stevens; Carson C Thoreen; Aurora A Burds; Nada Y Kalaany; Jason Moffat; Michael Brown; Kevin J Fitzgerald; David M Sabatini
Journal:  Dev Cell       Date:  2006-12       Impact factor: 12.270

3.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

Review 4.  Perturbations of the AKT signaling pathway in human cancer.

Authors:  Deborah A Altomare; Joseph R Testa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

Review 5.  Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.

Authors:  Ichiro Shiojima; Kenneth Walsh
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

6.  SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.

Authors:  Estela Jacinto; Valeria Facchinetti; Dou Liu; Nelyn Soto; Shiniu Wei; Sung Yun Jung; Qiaojia Huang; Jun Qin; Bing Su
Journal:  Cell       Date:  2006-09-07       Impact factor: 41.582

7.  PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.

Authors:  John Brognard; Emma Sierecki; Tianyan Gao; Alexandra C Newton
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

8.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

9.  Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction.

Authors:  Toshiyuki Takahashi; Tong Tang; N Chin Lai; David M Roth; Brian Rebolledo; Miho Saito; Wilbur Y W Lew; Paul Clopton; H Kirk Hammond
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690

10.  Modeling of Galpha(s) and Galpha(i) regulation of human type V and VI adenylyl cyclase.

Authors:  Misty Chen-Goodspeed; Abolanle N Lukan; Carmen W Dessauer
Journal:  J Biol Chem       Date:  2004-11-15       Impact factor: 5.157

View more
  15 in total

1.  Suppression of survival signalling pathways by the phosphatase PHLPP.

Authors:  Audrey K O'Neill; Matthew J Niederst; Alexandra C Newton
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

2.  Intracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial.

Authors:  H Kirk Hammond; William F Penny; Jay H Traverse; Timothy D Henry; Matthew W Watkins; Clyde W Yancy; Ranya N Sweis; Eric D Adler; Amit N Patel; David R Murray; Robert S Ross; Valmik Bhargava; Alan Maisel; Denise D Barnard; N Chin Lai; Nancy D Dalton; Martin L Lee; Sanjiv M Narayan; Daniel G Blanchard; Mei Hua Gao
Journal:  JAMA Cardiol       Date:  2016-05-01       Impact factor: 14.676

Review 3.  Prospects for gene transfer for clinical heart failure.

Authors:  T Tang; M H Gao; H Kirk Hammond
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

Review 4.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

5.  Beneficial effects of adenylyl cyclase type 6 (AC6) expression persist using a catalytically inactive AC6 mutant.

Authors:  Mei Hua Gao; Tong Tang; Ngai Chin Lai; Atsushi Miyanohara; Tracy Guo; Rouying Tang; Amy L Firth; Jason X Yuan; H Kirk Hammond
Journal:  Mol Pharmacol       Date:  2010-12-02       Impact factor: 4.436

6.  Ras-associating domain proteins: a new class of cyclic nucleotide-gated channel modulators.

Authors:  Vivek K Gupta; Ammaji Rajala; Raju V S Rajala
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 7.  Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.

Authors:  Mei Hua Gao; H Kirk Hammond
Journal:  J Mol Cell Cardiol       Date:  2011-02-23       Impact factor: 5.000

8.  beta(1)-Adrenergic receptor vs adenylyl cyclase 6 expression in cardiac myocytes: differences in transgene localization and intracellular signaling.

Authors:  Mei Hua Gao; Tong Tang; Atsushi Miyanohara; James R Feramisco; H Kirk Hammond
Journal:  Cell Signal       Date:  2009-11-20       Impact factor: 4.315

Review 9.  Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.

Authors:  Katrina F Ostrom; Justin E LaVigne; Tarsis F Brust; Roland Seifert; Carmen W Dessauer; Val J Watts; Rennolds S Ostrom
Journal:  Physiol Rev       Date:  2021-10-26       Impact factor: 37.312

Review 10.  On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.

Authors:  Kellie A Lemoine; Julianna M Fassas; Shirag H Ohannesian; Nicole H Purcell
Journal:  Cell Signal       Date:  2021-07-25       Impact factor: 4.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.